| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/07/2013 | WO2013033705A2 Non-natural nucleosides as theranostic agents |
| 03/07/2013 | WO2013033688A1 Treatment of cancer |
| 03/07/2013 | WO2013033640A1 Methods and compositions for detecting cancer based on mirna expression profiles |
| 03/07/2013 | WO2013033636A2 Methods for preparing high throughput peptidomimetics, orally bioavailable drugs and compositions containing same |
| 03/07/2013 | WO2013033629A2 Methods and compositions for the treatment and diagnosis of colorectal cancer |
| 03/07/2013 | WO2013033627A2 Diagnosis and treatment of arthritis using epigenetics |
| 03/07/2013 | WO2013033623A1 Profiling of signal pathway proteins to determine therapeutic efficacy |
| 03/07/2013 | WO2013033609A2 Methods and compositions for the treatment and diagnosis of cancer |
| 03/07/2013 | WO2013033597A1 Ssat mrna translation repression and activation |
| 03/07/2013 | WO2013033561A1 Vegf-specific capture agents, compositions and methods of using and making |
| 03/07/2013 | WO2013033541A1 Molecularly imprinted polymer for detecting waterborne target molecules and improving water quality |
| 03/07/2013 | WO2013033520A1 A method for regulating skin pigmentation |
| 03/07/2013 | WO2013033515A1 Compounds and methods for assaying redox state of metabolically active cells and methods for measuring nad(p)/nad(p)h |
| 03/07/2013 | WO2013033493A1 Humidity and temperature corrections to improve accuracy of hf ambient air monitors based on tunable diode laser ir absorption measurements |
| 03/07/2013 | WO2013033436A1 Oligonucleotide-based probes for detection of bacterial nucleases |
| 03/07/2013 | WO2013033383A2 Molecularly imprinted polymers for detection of contaminants |
| 03/07/2013 | WO2013033359A1 Carbon nanotube biosensors and related methods |
| 03/07/2013 | WO2013033319A2 A cluster of neutralizing antibodies to hepatitis c virus |
| 03/07/2013 | WO2013033283A1 Improving systemic glucose tolerance in type-2 diabetes |
| 03/07/2013 | WO2013033225A2 Voltage offset correction in high-throughput electrophysiological measurement system |
| 03/07/2013 | WO2013033148A1 Identification of mycoplasm contamination in biotechnology production using raman spectroscopy |
| 03/07/2013 | WO2013033092A2 Streptococcus suis pilus antigens |
| 03/07/2013 | WO2013033074A2 Methods and compositions to detect the level of lysosomal exocytosis activity and methods of use |
| 03/07/2013 | WO2013033060A1 Devices having a calibration control region, systems and methods for immunohistochemical analyses |
| 03/07/2013 | WO2013032953A2 Development and use of fluorescent probes of unbound bilirubin |
| 03/07/2013 | WO2013032942A1 Influenza viruses with mutant pb2 gene segment as live attenuated vaccines |
| 03/07/2013 | WO2013032918A1 Fumarylacetoacetate hydrolase (fah)-deficient and immunodeficient rats and uses thereof |
| 03/07/2013 | WO2013032877A1 Warranty violation detection system for disallowed fuels |
| 03/07/2013 | WO2013032689A2 Dye compositions |
| 03/07/2013 | WO2013032686A1 Flowable dry powder composition |
| 03/07/2013 | WO2013032601A1 Kit for sampling and detection of endotoxin in aqueous solution |
| 03/07/2013 | WO2013032598A1 Modular roller oven for simulating borehole conditions and associated methods |
| 03/07/2013 | WO2013032594A1 Modular roller oven for simulating borehole conditions and associated methods |
| 03/07/2013 | WO2013032460A1 Cervico-vaginal sample collection kit |
| 03/07/2013 | WO2013032313A2 Time-temperature integrator including micro-immobilized microbial beads, and method for manufacturing same |
| 03/07/2013 | WO2013032242A2 Target non-binding aptamer selection method using graphene and aptamer selected therefrom |
| 03/07/2013 | WO2013032095A1 Detection method using colorimetric analysis |
| 03/07/2013 | WO2013031757A1 Marker for detecting pancreatic cancer, breast cancer, lung cancer, or prostate cancer, and examination method |
| 03/07/2013 | WO2013031756A1 Marker for detecting colorectal cancer or esophageal cancer and method for inspecting same |
| 03/07/2013 | WO2013031421A1 Embedding tray |
| 03/07/2013 | WO2013030799A1 B cell assay |
| 03/07/2013 | WO2013030785A1 Biomarkers for lysosomal storage disorders |
| 03/07/2013 | WO2013030645A1 Dye entrapped sol-gel film based test strip sensor for nitrate and a process of preparing said strip sensor |
| 03/07/2013 | WO2013030601A1 Method and device for detecting an analyte |
| 03/07/2013 | WO2013030579A1 Method for detecting nucleosomes containing histone variants |
| 03/07/2013 | WO2013030578A2 Method for detecting nucleosomes |
| 03/07/2013 | WO2013030577A1 Method for detecting nucleosomes containing nucleotides |
| 03/07/2013 | WO2013030544A1 Device, method and apparatus for the transfer of analytes |
| 03/07/2013 | WO2013030542A1 Detection of neurodegenerative disease |
| 03/07/2013 | WO2013030541A1 Histone deacetylase |
| 03/07/2013 | WO2013030525A1 Explosive and narcotics detection dog training with vapour or aerosol air impregnation |
| 03/07/2013 | WO2013030524A1 Assay device comprising an optical filter and a method of assaying |
| 03/07/2013 | WO2013030523A1 Methods of triggering activation of encapsulated signal-generating substances and apparatus utilising activated signal-generating substances |
| 03/07/2013 | WO2013030462A1 Device and method for characterizing solid matter present in liquids |
| 03/07/2013 | WO2013030430A1 Device, system and method for measuring moisture of structure material |
| 03/07/2013 | WO2013030032A1 A method for predicting clinical benefit in the treatment of neurodevelopmental, neurological or neuropsychiatric disorders |
| 03/07/2013 | WO2013029631A2 Enzyme detection by microfluidics |
| 03/07/2013 | WO2013029625A1 Apparatus for measuring the metabolic rate of motile organisms |
| 03/07/2013 | WO2013029609A2 Carrier material for electrically polarisable biomaterials, polyelectrolyte materials, atoms, ions and molecules; production and use thereof |
| 03/07/2013 | WO2013029546A1 Image-based method for measuring elasticity of biological tissues and system thereof |
| 03/07/2013 | WO2013029472A1 Composition, kit and use thereof for quickly extracting unrelated circulating nucleated cell from peripheral blood of diseased animal model |
| 03/07/2013 | WO2013029181A1 Method and system for abo antibody detection and characterization |
| 03/07/2013 | WO2013029159A1 Method and system for pre-programmed self-power microfluidic circuits |
| 03/07/2013 | WO2013029155A1 Methods and devices for multiplexed microarray microfluidic analysis of biomolecules |
| 03/07/2013 | WO2013029153A1 Centrifugally-enhanced capture method and device |
| 03/07/2013 | WO2013029139A1 Fluorescent polyaniline nanoparticles |
| 03/07/2013 | WO2013029115A1 Electrochemical competition sensor |
| 03/07/2013 | WO2013029114A1 Electrochemical affinity sensor |
| 03/07/2013 | WO2013029106A1 Method for hydrogen sulfide detection |
| 03/07/2013 | WO2013029082A1 Method for detecting fluid injection in a patient |
| 03/07/2013 | WO2013022322A9 Composition for mass analysis of haptoglobin and method for diagnosing cancer using same |
| 03/07/2013 | WO2013011513A9 Methods of determining enzyme activity in preserved cell samples |
| 03/07/2013 | WO2013011323A3 Apparatus and method for lateral flow affinity assays |
| 03/07/2013 | WO2013010106A3 Three dimensional microfluidic multiplexed diagnostic system |
| 03/07/2013 | WO2013009106A9 Method and apparatus for measuring a residual chloride concentration using a sensor, and water treatment system using the method and apparatus |
| 03/07/2013 | WO2013006474A3 Requlatora t cells and methods of identifying and isolating them using cd6 -expression or the combination of cd4, cd25 and cd127 |
| 03/07/2013 | WO2012172347A9 Diagnosing and treating inflammatory bowel disease and irritable bowel syndrome |
| 03/07/2013 | WO2012172345A3 Treating conditions associated with allergy |
| 03/07/2013 | WO2012172343A3 Treating primary sclerosing cholangitis |
| 03/07/2013 | WO2012172342A3 Treating multiple sclerosis |
| 03/07/2013 | WO2012172340A3 Treating mental disorders |
| 03/07/2013 | WO2012172339A3 Treating inflammatory arthritis |
| 03/07/2013 | WO2012172337A3 Treating cardiovascular disease |
| 03/07/2013 | WO2012172336A3 Treating inflammatory skin diseases |
| 03/07/2013 | WO2012167112A9 Gastric cancer biomarkers |
| 03/07/2013 | WO2012166971A3 Method of assessing risk of pml |
| 03/07/2013 | WO2012166954A3 Systems and methods for estimating photosynthetic carbon assimilation |
| 03/07/2013 | WO2012164350A3 Apparatus and method for characterizing parameters for the cracking, in-situ combustion, and upgrading of hydrocarbons |
| 03/07/2013 | WO2012156665A3 Methods and compositions relating to platelet sensitivity |
| 03/07/2013 | WO2012151289A3 Method and system to detect aggregate formation on a substrate |
| 03/07/2013 | WO2012148230A3 Screening method of therapeutic agent for bipolar disorders |
| 03/07/2013 | WO2012144871A3 Diagnostic and therapeutic method for glioma through identification of protein relocation |
| 03/07/2013 | WO2012144861A3 Method for analyzing protein-protein interaction on single-molecule level in cell environment, and method for measuring density of protein activated in cytosol |
| 03/07/2013 | WO2012141531A3 Method for screening inhibitory substances to inflammatory skin-aging |
| 03/07/2013 | WO2012140429A3 Method and apparatus for the analysis of biological samples |
| 03/07/2013 | WO2012139052A3 Antibody biomarkers for diabetes |
| 03/07/2013 | WO2012139051A3 Autoantibody biomarkers for iga nephropathy |
| 03/07/2013 | WO2012138176A3 D-aptide and retro-inverso aptide with maintained target affinity and improved stability |
| 03/07/2013 | WO2012112730A3 Compositions and methods for delivering nucleic acid to a cell |
| 03/07/2013 | WO2012096545A3 Novel pancreatic cancer biomarker using the characteristics of pancreatic cancer stem cells, and use thereof |